ASPRIN FOR PRIMARY PREVENTION

March 6, 2020 by Imara Mediplus0
Asprin-10-1200x1200.jpg

Aspirin has been in use over the years for primary prevention of major adverse cardiovascular events (MACE) a composite of non-fatal stroke, non-fatal myocardial infarction and cardiovascular death.

In a metanalysis on comparison of contemporary versus older studies it was noted aspirin had a significant reduction on MACE and a significant increase in the risk of major hemorrhage and intracranial hemorrhage

It was also noted that aspirin has no mortality benefit when used for primary prevention.

Statins use has however reduced the risk of non-fatal MI when used for primary cardiovascular prevention.

All over the world different guidelines are in use on aspirin for primary prevention of cardiovascular events.

In conclusion more, studies need to be done to come up with one guideline on who and when aspirin should be used for primary prevention of MACE, however as for the metanalysis recommendation made was not to use aspirin for primary prevention.

Reference:

Family Practice, 2019,1_7 doi:10.1093/fampra/cmz080


Leave a Reply

Your email address will not be published. Required fields are marked *


Imara Mediplus Hospital

We are a multi-speciality healthcare facility founded and managed by doctors, focused on providing holistic care all under one roof.

The goal of The Imara Mediplus is to provide our clients with the all necessary services required to achieve both health and wellness. We seek to conveniently serve any person in need of friendly, professional, quality assured medical services, without the worry of cost.

Copyright - Imara Mediplus Hospital 2018-2020. All rights reserved.